Osteoporosis and Osteomalacia
Whitney Goldner, Joseph S. Dillon
Abstract
Whitney Goldner, Joseph S. Dillon
Abstract
Osteoporosis is a metabolic bone disorder characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced fragility and a consequent increase in fracture risk (1). Clinically, it is defined by evidence of osteopenia associated with a fracture, or history of fractures with minimal trauma. It is defined quantitatively as a bone mineral density (BMD) of less than 2.5 SD below the mean gender-matched maximal bone density (1).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Osteoporosis is a metabolic bone disorder characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced fragility and a consequent increase in fracture risk (1). Clinically, it is defined by evidence of osteopenia associated with a fracture, or history of fractures with minimal trauma. It is defined quantitatively as a bone mineral density (BMD) of less than 2.5 SD below the mean gender-matched maximal bone density (1).
Key concepts: Osteopenia, Osteomalacia, Osteoporosis, Bone mineral, Medicine, Bone mass, Bone density, Internal medicine